HomeAI · summaries
Storia in 2 fonti
Canada’s Drug Agency recommends funding lecanemab for early-stage Alzheimer’s disease
TORONTO - Canada's Drug Agency is recommending that public drug plans pay for a treatment shown to slow the progression of early-stage Alzheimer's disease if patients meet certain conditions.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
medpagetoday.com
FDA Approves At-Home Starter Dose of Alzheimer's Drug
Lecanemab decision marks first time patients can begin treatment with home administration
- ·
thestar.com
Canada’s Drug Agency recommends funding lecanemab for early-stage Alzheimer’s disease
TORONTO - Canada's Drug Agency is recommending that public drug plans pay for a treatment shown to slow the progression of early-stage Alzheimer's disease if patients meet certain…